There is controversy of whether prophylaxis treatment or a ''screen and treat'' policy should be adopted for preventing infective complications when women undergo abortion. There is currently compelling evidence that indicates that a universal policy of prophylaxis treatment to all women undergoing abortion should receive antibiotics. It is also a cost-effective policy.
|Number of pages||3|
|Journal||The European Journal of Contraception and Reproductive Health Care|
|Publication status||Published - 1 Jan 2007|